tiprankstipranks
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market
Holding GB:AGY?
Track your performance easily

Allergy Therapeutics (AGY) Ownership - Who Owns Allergy Therapeutics?

14 Followers

Allergy Therapeutics (AGY) Ownership Overview

0.12%99.88%
0.12% Other Institutional Investors
99.88% Public Companies and
Individual Investors
The ownership structure of Allergy Therapeutics (GB:AGY) stock is a mix of institutional, retail, and individual investors. , and 99.88% is owned by Public Companies and Individual Investors.
The ownership structure of Allergy Therapeutics (GB:AGY) stock is a mix of institutional, retail, and individual investors. , 0.12% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Allergy Therapeutics PLC (GB:AGY)?
Currently, no data Available
What percentage of Allergy Therapeutics PLC (GB:AGY) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.12% of Allergy Therapeutics PLC (GB:AGY) stock is held by institutional investors.
    What percentage of Allergy Therapeutics PLC (GB:AGY) stock is held by retail investors?
    According to the latest TipRanks data, approximately 99.88% of Allergy Therapeutics PLC (GB:AGY) stock is held by retail investors.
      Who owns the most shares of Allergy Therapeutics PLC (GB:AGY)?
      Currently, no data Available
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis